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Abstract
In schizophrenia, explicit learning deficits have been well established although it is less clear whether these patients have
deficits in implicit learning (IL). IL is thought to depend on intact striatal functioning. This study examined the hypothesis that
schizophrenia patients show deficient recruitment of striatal activation during an IL paradigm, relative to performance-matched
healthy comparison subjects. Ten subjects with schizophrenia on atypical antipsychotic medication and 10 age, gender, education,
and performance matched healthy comparison subjects underwent fMRI while performing an IL task. On the basis of whole-brain
and striatal region-of-interest analyses, we found a relative lack of striatal activation in schizophrenia patients. This result is
consistent with convergent evidence of striatal dysfunction in schizophrenia.
© 2006 Elsevier B.V. All rights reserved.
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1. Introduction
While there is general acceptance of there being
explicitlearningdeficitsinschizophrenia(Fioravantietal.,
2005; Green et al., 1997, 2000; Heinrichs and Zakzanis,
1998; Lussier and Stip, 2001; Saykin et al., 1994)a n di n
biological relatives of schizophrenia patients (Sponheim
et al., 2004), findings are less consistent in regard to
implicitlearning(IL)deficits.MoststudiesreportintactIL
in schizophrenia (Bazin et al., 1996; Bazin and Perruchet,
1996;Clareetal.,1993;Danionetal.,2001;Domineyand
Georgieff, 1997; Gopal, 1997; Granholm et al., 1993;
Gras-Vincendonetal.,1994;Kazesetal.,1999;Kerietal.,
2000; Kern et al., 1997; Ninomiya et al., 1998; Schmand
etal., 1992a,b;Sponheim etal.,2004; Wexleretal., 1997;
Wooningsetal.,2002),thougha minoritysuggeststhatIL
is impaired (Bressi et al., 1998; Giménez et al., 2003;
Goldberg et al., 1990; Green et al., 1997; Kumari et al.,
2002; Randolph et al., 1993; Schwartz et al., 2003). One
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ARTICLE IN PRESSreason for this discrepancy may relate to the specific type
of IL being studied such as priming, visuomotor, and
problem solving tasks. Sequence learning tasks appear
most likely to reveal deficient learning in schizophrenia
(Bressietal.,1998;Greenetal.,1997;Kumarietal.,2002;
Schwartz et al., 2003). Consequently, implicit sequence
learningmaybedependentonaparticularneuralsubstrate
that is impaired in schizophrenia.
It is also possible that the periodically observed IL
deficits may relate to the effect of dopamine antagonist
antipsychoticmedicationratherthantheunderlyingillness.
Impaired IL has been reported in healthy participants
administeredhaloperidol(Kumarietal.,1997;Perettietal.,
1997), and chlorpromazine (Danion et al., 1992), with
enhancedILoccurringwiththedopamineagonist,amphet-
amine (Kumari et al., 1997). Investigations have demon-
strated largely intact IL in schizophrenia with patients
taking atypical antipsychotic medication, but impaired IL
with the older, typical class of antipsychotic medication
(Paquet et al., 2004; Schérer et al., 2004; Stevens et al.,
2002). Moreover, IL has improved in schizophrenia
patients after being switched to an atypical antipsychotic
(Purdon et al., 2000).
Appropriatefunctioningofthestriatumanditsconnec-
tedneuralsubstratesarethoughttobecriticalforadequate
performance in IL tasks (Curran, 1998). Individuals with
striatalpathology,suchasinHuntington's(Knopmanand
Nissen, 1991; Willingham and Koroshetz, 1993)a n d
Parkinson's disease (Doyon et al., 1997; Pascual-Leone
etal.,1993),demonstrateimpairedIL.Functionalimaging
studies have reported striatal activation in participants
who displayed IL (Grafton et al., 1995; Peigneux et al.,
2000; Martis et al., 2004; Rauch et al., 1995, 1997a,b,
1998), and a recent paper has further consolidated this
relationship with the use of a control group (Reiss et al.,
2005). Other motor-associated areas have been correlated
with IL including primary motor cortex, premotor cortex,
supplementary motor area and the cerebellum (Grafton
etal.,1992,1995;Jueptneretal.,1997).Moreperceptually
oriented areas have also been associated with IL such as
parietalandtemporalcortices,aswellasthehippocampus
(Curran, 1998; Schendan et al., 2003), though all these
areas are less consistently reported than the striatum.
Typicalantipsychotics bindtostriataldopaminerecep-
tors thereby potentially impairing IL, whereas atypical
antipsychoticshavemuchlesseffectonthestriatum(Blin,
1999; Chiodo and Bunney, 1983; Grace, 1992; Kapur
et al., 1995; Kapur, 1998). Yet there is reason to suspect
striatal abnormalities exist in schizophrenia itself. Struc-
turalimagingstudieswithmedication-naïvepatientshave
reported striatal abnormalities (Corson et al., 1999; Gur
et al., 1998; Lang et al., 1999, 2001). Moreover, medi-
cation-naïve patients have been reported to have extra-
pyramidal symptoms, suggesting intrinsic striatal
dysfunction (Caligiuri and Lohr, 1997; Chatterjee et al.,
1995;Cortese,2001;Purietal.,1999).Further,Granholm
et al. (1993) demonstrated that the severity of tardive
dyskinesia in schizophrenia was associated with both
shortened caudate T2 relaxation times and decreased IL.
More recently, Giménez et al. (2003) found an inverse
correlation between caudate metabolism (NAA/Cho
ratio) and IL in schizophrenia.
Therehas beenone fMRI investigationtodatethathas
evaluated IL in participants with schizophrenia (Kumari
etal.,2002).Inthisstudy,usingaserialreactiontimetask,
six healthy controls demonstrated significantly greater
activations in the striatum, thalamus, precuneus, and sen-
sorimotor regions than the six schizophrenia participants
whoweretakingtypicalantipsychoticmedication.Impor-
tantly,whilethecontrolsdemonstratedrobustevidenceof
IL, the patients did not whatsoever. This marked dis-
crepancy in task performance limits the interpretation of
neural activation differences (Rauch et al., 2001)b e c a u s e
it can be argued that the two groups were not engaged in
the samecognitive processes while undergoing fMRI, i.e.
the controls were learning but the patients were not.
Given these discrepant findings on IL in schizophre-
nia, the current study evaluates the neural basis of an
implicit sequence learning task in schizophrenia partici-
pants taking atypical antipsychotics and who demonstrat-
ed equivalent learning to controls. We chose to utilize a
sequence learning task, as this type of IL has been the
most likely to reveal differential performance in patients
with schizophrenia as compared to healthy controls
(Bressi et al., 1998; Green et al., 1997; Kumari et al.,
2002; Schwartz et al., 2003). In addition to a whole-brain
exploratory analysis, we conducted an a priori region of
interestanalysisofthestriatum,givenitspivotalroleinIL
and postulated role in schizophrenia. We hypothesized
that the schizophrenia group would demonstrate less
striatal activation than the control group, despite similar
behavioral performance on the IL task.
2. Materials and methods
2.1. Participant selection
We examined 20 right-handed (Oldfield, 1971) volun-
teers, 10 with schizophrenia, and 10 age, gender, and
education matched healthy controls, through outpatient
clinic contacts and poster advertisements. Task perfor-
mance was comparable between the two groups (Table 1),
and so no participant selection actions were needed. The
studyandallprocedureswereconductedwiththeapproval
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Council, Institute for Biodiagnostics, research ethics
boards.Allparticipantsprovidedsigned,informedconsent.
2.2. Sample characteristics
Administration of the MINI International Diagnostic
Interview version 5.0 (Sheehan et al., 1998) for DSM-IV
(American Psychiatric Association, 1994) confirmed that
all clinical participants had a diagnosis of schizophrenia
with no co-morbid conditions. Clinical participants were
assessed with the Positive and Negative Syndrome Scale
for Schizophrenia (PANSS) (Kay et al., 1987)w h i c h
provided a total, as well as subscale scores for positive,
negative, and general psychopathology symptoms.
Schizophrenia illness duration ranged from 3 to
41 years (mean and SD in Table 1). All schizophrenia
participantswereonstabledosesofatypicalantipsychotic
medication, which were converted to chlorpromazine
equivalent doses (Woods, 2002)( s e eTable 1). Partici-
pants with schizophrenia did not differ significantly from
healthy controls on age, gender, or education (Table 1).
2.3. Task
We used the serial reaction time (SRT) task (Martis
et al., 2004, Rauch et al., 1997a,b) for which MRI-com-
patible eye-pieces displayed an asterisk in one of four
horizontally arranged boxes for 1.0 s, followed by a 0.2
second empty-boxes interval. Using separate fingers, parti-
cipants pressed one of four keys in immediate response to
an asterisk. A 25-trial practice run was followed by two
312-trialruns(eachlasting6.25min).Eachrunconsistedof
alternating blocks of random (R) and IL conditions brack-
eted by a 19.2-second cross-hair fixation block. In the IL
condition, the stimuli followed a 12-item sequence (posi-
tion: 1-2-1-4-2-3-4-1-3-2-4-3) that repeated six times. In
the R condition, 24 trials were pseudo-randomly presented
with no immediately repeated locations. No signs were
given to distinguish between R and IL blocks. For each
participant, a median reaction time (RT) score was calcu-
lated for each condition, R and IL, and an IL reaction time
advantage (RTa) score [100⁎(R-IL)/R]. RT estimates
were based on correct trial responses.
2.4. Debriefing
Following the scan, participants were informed of and
a s k e dt or e p r o d u c et h er e p e a t i n gs e q u e n c eb ym a k i n g1 5
key presses (Martis et al., 2004; Rauch et al., 1997b). The
longest string that matched the 12-item implicit sequence
estimated the degree of explicit learning. Scores ≥7w e r e
categorized as explicit learning (see Martis et al., 2004).
2.5. MRI acquisition
Images were acquired on a General Electric 1.5 Tesla
MRI system with a clinical transmit/receive head coil.
Anatomical scans for each individual used a T1-weighted
fast spin-echo sequence (TR/TE/FOV=400/8 ms/25 cm,
2 mm slice thickness) for a 2×1×1 mm voxel image.
FunctionalMRIdatausedasingle-shotgradient–recalled-
Table 1
Sociodemographic, clinical status, and behavioral performance of the participants
Schizophrenia (n=10)
mean (SD)
Control (n=10)
mean (SD)
t(18) p Grand mean
(n=20)
Sociodemographics
Gender: female/male 1/9 1/9 –– 2/18
Age (years) 29.1 (9.4) 26.1 (7.1) 0.80 .43 27.6 (8.3)
Education (years) 12.8 (2.5) 13.4 (2.4) −0.54 .59 13.1 (2.4)
Clinical measures
Medication dosage (chlorpromazine equivalents mg/d) 330 (180) n/a
PANSS 69.0 (8.2)
a n/a
Illness duration (years) 11.5 (12) n/a
Serial reaction time task behavior performance
Reaction time (ms)
b
Random 415.5 (77.0) 411.7 (53.9) −0.13 .90 413.6 (64.7)
Implicit learning 398.7 (75.6) 389.7 (55.3) −0.31 .76 394.2 (64.6)
Reaction time advantage (%)
c 4.1 (2.9) 5.4 (4.7) −0.75 .46 4.8 (3.9)
Error rates 4.9 (4.1) 2.9 (1.9) −1.4 .19 3.9 (3.3)
Explicit learning scores 3.7 (0.7) 4.3 (1.3) 1.3 .22 4.0 (1.1)
an=9;
bReactiontimebasedonthemeanofmedianreactiontimesinmillisecondswiththeSDinbrackets;
c%RTadvantage=100⁎(baselineRT−implicit
RT)/baseline RT.
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angle/FOV=2400/60ms/45°/25cm.Approximately80%
of the brain was imaged using 23 contiguous axial slices
and 3.9 mm isotropic voxels excluding the most superior
and inferior brain regions. In each experimental run,
172 volumes were acquired (344 volumes in total).
2.6. fMRI individual analyses
Image analyses were performed with Analysis of
Functional NeuroImages (AFNI) software (Cox, 1996).
The fMRI data were slice time-corrected. Functional vol-
umes were co-registered to the volume that minimized
translation and rotation relative to all other volumes. The
first 3 volumes were excluded to allow for equilibrium of
the MRI signal. One additional volume (out of 344) with
visually detectable movement (0.3 degrees of pitch ro-
tation and 0.4 mm) was excluded in one person with
schizophrenia. Run 2 was concatenated to Run 1. The
block design time-series was convolved to account for the
hemodynamic response function. Multiple regression an-
alysis included nine regressors: 2 convolved IL and R
condition regressors, 3 head-motion covariates (i.e., roll,
pitch, and yaw), 2 slope regressors (1 per Run), and
2 intercept (fixation cross-hair blocks) regressors (1 per
Run). The beta coefficient for each condition (IL and R)
was divided by the mean fixation cross-hair coefficient to
estimate percent blood oxygen level dependent (BOLD)
signal change for each condition (Cohen and DuBois,
1999). Beta values represent partial signal change when
simultaneouslyalsotakingintoaccountthebaseline,linear
drift, and movement nuisance regressors. To account for
anatomical variations, an 8 mm full-width half-maximum
Gaussian filter was applied. Data were transformed into
the Montreal Neurological Institute (MNI) coordinates.
2.7. Alpha control criteria
For the whole brain analyses, Monte Carlo simula-
tions estimated that a voxel-wise probability of pb0.02
and a minimum cluster volume of 640 μl would main-
tain an overall pb0.05. For the striatum (defined via the
AFNI software atlas) Region of Interest (ROI) analyses,
a more liberal criterion was used. ROI Monte Carlo
simulations estimated that a voxel-wise probability of
pb0.04 and a minimum cluster volume of 448 μl would
maintain an overall pb0.05.
2.8. fMRI between- and within-group analyses
A2×2repeatedmeasuresANOVAwasusedtoidentify
common IL-related BOLD responses (condition effect)
and group differences in IL-related BOLD responses
(group by condition interactions). ANOVA cluster aver-
ages were imported into SPSS for descriptive statistic and
simple effect analyses. To supplement these analyses, we
tested for degree of IL-related (RTa) BOLD responses
withineachgroupaswellasRTabygroupinteractions.All
areas of activation are reported in Montreal Neurological
Institutecoordinates withpositivevaluesasright,anterior,
and superior. For each IL-related activation cluster iden-
tified,wetestedforcorrelationsbetweenBOLDresponses
and PANSS scores and medication dosage.
3. Results
3.1. Task performance
Schizophrenia patients and controls did not differ on
mean RT or RTa (Table 1). Each group showed faster
meanRTduringtheILconditioncomparedtotherandom
condition[schizophrenia,t(9)=4.5,pb.001,andcontrols,
t(9)=3.6, pb.006]. Total error rates (commissions and
omissions) and mean explicit learning estimates did not
differ between groups (Table 1). There was no correlation
between symptom severity, i.e. PANSStotal and subscale
scores, and task performance measures, i.e. RTa and per-
cent correct (all p valuesN.70). As well, medication dos-
age was not correlated with task performance RTa scores,
pN.70, or percent correct, pN.35.
3.2. Common IL vs. R BOLD responses
Three brain regions were identified showing greater
BOLD response to IL trials compared to R trials in both
groups (Table 2). Post hoc simple effect analyses
Table 2
Brain regions showing greater blood oxygen level dependent (BOLD)
responses to the IL minus R condition in both groups (common
condition effect)
Brain region BA xyzVol.
(μl)
F
(1,18)
Mn IL-R
HC Sz
L middle
temporal
22 −50 −34 3 2432 16.0 0.11⁎ 0.09⁎
R superior
temporal
38 38 4 −14 1856 18.7 0.15⁎ 0.18⁎
L inferior
frontal
47 −38 20 −8 1344 20.3 0.08⁎ 0.12⁎
BA = Brodman Area, x, y, z = Montreal Neurological Institute
coordinates of maximally activated voxel, Vol. = volume, L = left,
R = right, Mn IL−R = mean difference of implicit learning minus
random condition % BOLD scores. ⁎ = Significantly different from
zero, pb05.
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significant BOLD response in these three brain regions.
3.3. Group differences in IL vs. R BOLD responses
Eightbrainregionswereidentifiedshowingsignificant
group-by-task condition BOLD responses (Table 3a).
Simple effect post hoc analyses determined that the con-
trolgroupexhibitedsignificantlyhigherBOLDresponses
totheILconditionthantheRconditioninalleightregions
(Table 3a). In contrast, the schizophrenia group exhibited
lower BOLD responses to the IL condition than the R
conditionintheseregionswithsignificantdecreasesinsix
of the eight regions (Table 3a). Note the thalamic cluster
of differential activation included the left caudate.
3.4. Other control group activations in IL vs R BOLD
responses
Whole brain repeated measures ANOVA identified
two additional regions that showed a significant
BOLD response in the control group for the IL vs. R
contrast, namely the left cuneus and the right caudate tail
(Table 3b). For the schizophrenia group, these regions
did not differ significantly in the IL vs. R contrast.
3.5. Striatal region of interest group differences
The left caudate showed a significant group-by-task
condition interaction in BOLD response (Table 4aa n d
Fig. 1a). Simple effect post hoc analyses determined that
the control group exhibited significantly higher BOLD
responses to the IL condition than the R condition, while
the schizophrenia group exhibited a non-significant de-
crease to the IL compared to the R condition (Table 4a).
This region partially overlaps with the thalamic/caudate
region identified in the whole brain interaction analysis.
The control group showed a significantly greater BOLD
responsetotheILvs.Rcontrastinasecondcaudateregion
(Table 4ba n dFig. 1b ) .T h i sr e g i o ns h o w e dn os i g n i f i c a n t
difference among the schizophrenia group (Table 4b). In
these two regions, the control group showed greater
absolute BOLD responses to the IL condition (pb.01) as
well as greater IL vs. R relative BOLD responses (Fig. 1).
3.6. Region of interest RTa-BOLD associations
Inthevoxel-by-voxelROIanalysis,amongthecontrol
group,degreeofILwas associatedwithgreateractivation
in the left striatum (volume=1088 μL), r=.87,pb.001,
with the maximum intensity voxel located in the left
putamen (x=−18, y=12,z=−4, t(8)=3.1, pb.02). In the
voxel-by-voxelROI analysesfor the schizophrenia group
only a trend level cluster was identified (overall pb.1).
For this trend level cluster, degree of IL was associated
with greater average cluster BOLD response within the
left caudate (volume=512 μL), r=.71, pb.03, with the
maximum intensity voxel at the MNI coordinates of x=
−14, y=11,z=9(t(8)=2.6, pb.05).
Table 3
Brain regions showing group differences in blood oxygen level
dependent (BOLD) responses to the IL minus R contrast (group by
condition interaction effect)
Brain region BA xyz F
(1,18)
Vol.
(μl)
Mn IL−R
HC Sz
a. Group by condition interactions
L medial
frontal
8 −6 38 46 14.0 1792 0.11⁎ −0.08⁎
R/L
thalamus
(includes
L caudate)
2 −6 17 16.3 1280 0.13⁎ −0.13⁎
L precentral 6 −42 −7 43 20.9 1088 0.06⁎ −0.09⁎
R superior
temporal
41 59 −26 12 19.7 704 0.10⁎ −0.04
L culmen 30 −6 −46 3 16.4 640 0.12⁎ −0.10⁎
L posterior
cingulate
30 −14 −63 10 22.7 640 0.10⁎ −0.10
R cingulate 24 14 −3 43 12.3 640 0.07⁎ −0.08⁎
R precentral 4 38 −20 42 12.8 640 0.09⁎ −0.08⁎
b. Group-specific condition effect
L cuneus 19 −2 −85 35 1280 16.9 0.21⁎ 0.06
R caudate
tail
22 −47 15 832 13.9 0.10⁎ 0.06
BA = Brodman area, x, y, z = Montreal Neurological Institute
coordinates of maximally activated voxel, IL = implicit learning, R =
random condition, Vol. =volume, L= left, R =right,Mn IL−R=mean
difference of IL minus R % BOLD scores. ROI = region of interest
analysis, ⁎ = significantly different from zero, pb.05.
Table 4
Striatal region of interest group differences in blood oxygen level
dependent (BOLD) responses to the IL minus R condition
BA xy z Vol.
(μl)
F(1,18) Mn IL−R
HC Sz
a. Group by condition interaction
L caudate −10 −6 17 448 8.5 0.12⁎ −0.06
b. Group-specific condition effect
L caudate −14 11 18 512 8.0 0.11⁎ 0.04
BA = Brodman area, x, y, z = Montreal Neurological Institute
coordinates of maximally activated voxel, IL = implicit learning, R =
random condition, Vol. =volume, L=left, R =right,Mn IL−R=mean
difference of IL minus R condition % BOLD scores. ROI = region of
interest analysis, ⁎ = significantly different from zero, pb.05.
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In the whole brain analysis, among the control group no
clusters of activation were associated with the degree of IL.
In contrast, among the schizophrenia group, degree of IL
was associated with BOLD responses in two regions: the
left dorsolateral prefrontal cortex (DLPFC, volume=
1216 μL), r=.95, pb.001, and the left anterior cingulate
cortex (ACC, volume=832 μL), r=.84, p b.002. More
specifically, degree of IL was associated with greater
BOLD responses in the left DLPFC (BA 10) with the
maximum intensity voxel at the MNI coordinates of x=
−34,y=43,z=20(t(8)=3.0,pb.02),andtheleftACC(BA
24,33) with the maximum intensity voxel at the MNI
coordinates of x=−2, y=14,z=23(t(8)=3.4, pb.01).
3.8. RTa-BOLD interactions
Interactions between degree of IL (RTa scores) and
group were tested using both the whole brain and ROI
analyses criteria. No significant clusters were identified.
However, a borderline significant (overall pb.1) inter-
actioncluster was foundthatlargelyoverlapswiththe left
ACC cluster associated with greater IL in the schizophre-
nia group. Thus, the positive association between degree
of IL and left ACC BOLD response is unique to the
schizophrenia group.
3.9. Schizophrenia symptom severity and medication
dosage correlations to BOLD responses
Schizophrenia symptom severity estimates (PANSS
total and subscale scores) were not correlated with any
of the BOLD responses in the patient group, pN.20.
Similarly, medication dosage was not correlated to any
of the BOLD responses, pN.15.
4. Discussion
This investigation found that schizophrenia patients
show reduced striatal activation relative to performance-
matched healthy comparison subjects during an IL task,
which supports our hypothesis of deficient recruitment of
the striatum.
Fig. 1. Group differences in blood oxygen level dependent (BOLD) responses to the implicit learning (IL) condition compared to the random (R)
condition in the striatum region-of-interest analyses. The group by condition interaction is labeled “a” and the control-specific condition effect is
labeled “b”. The 95% confidence intervals in the bar charts reveal a significant IL minus R (IL−R) effect for the control group (HC) and a non-
significant IL effect for the schizophrenia group (Sz).
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of IL-related activation, invoking frontostriatal circuits,
multiple temporal lobe areas, and motor cortices, all areas
previously reported with this type of task (Grafton et al.,
1995; Peigneux et al., 2000; Rauch et al., 1995, 1998;
Schendanetal.,2003;Thomasetal.,2004).Incontrast,the
schizophrenia participants, despite equivalent behavioural
performance, recruited fewer brain regions, restricted to
the middle and superior temporal, and inferior frontal
cortices. Of particular note, participants with schizophre-
nia failed to activate the striatum to the same degree as
controls,this areabeingconsidereda pivotalpartoftheIL
neuralnetwork (Doyon et al.,1997;Peigneuxetal.,2000;
Rauch et al., 1997a,b; Reiss et al., 2005; Willingham and
Koroshetz, 1993). This functional neuroimaging finding
complements previous evidence of striatal abnormalities
in schizophrenia, as summarized in the Introduction. Not-
withstanding,thestriatalregion-of-interestRTacorrelation
analysis trend-level result in the schizophrenia group is
suggestive of some degree of striatal recruitment in task
performance in schizophrenia. Moreover, the schizophre-
nia whole-brain RTa correlation analysis results are pos-
sibly reflective of this group having their IL performance
mediated through non-striatal regions (ACC and DLPFC).
Taken together, in both healthy controls and especially in
schizophrenia subjects, IL task performance is not ex-
clusively dependent on striatal involvement.
The finding of the schizophrenia group invoking the
ACC and DLPFC in relation to improving task perfor-
mance is intriguing. Both the ACC (Kumari et al., 2002;
Peigneuxetal.,2000;Rauchetal.,1997b)andtheDLPFC
(Grafton et al., 1995; Schendan et al., 2003) have been
associated with the conduct of implicit sequence tasks.
Additionally, Snitz et al. (2005) recently demonstrated
hypoactivation of the DLPFC and ACC in unmedicated
first-episode patients doing a cognitive task designed to
dissociatethetworegions.After4weeksoftreatmentwith
atypical antipsychotics, a subset of these patients was
rescanned and demonstrated increased/normalized acti-
vation of the ACC, but not of the DLPFC. However,
Honey et al. (1999) reported increased ACC/supplemen-
tary motor area and DLPFC activation in a working
memory task when patients were switched from typical
antipsychoticmedicationstorisperidone.Moreover,ithas
been shown that both clozapine (Lahti et al., 2004)a n d
olanzapine (Lahti et al., 2005) enhance ACC regional
cerebral blood flow when given to medication-free pa-
tients. Hence, our schizophrenia group demonstrated
normal behavioural performance which was conceivably
partially mediated through the ACC and DLPFC, and in
turn this effect may have been enabled by atypical anti-
psychotic medication.
Our patients were taking only atypical antipsychotic
medication, with the expectation of them demonstrating
intact IL. Consistent with this assumption, a recent
neuroimaging study involvingIL in schizophrenia (Paquet
et al., 2004) used SPECT to assess the effects of two
antipsychotic drugs on IL and striatal dopamine (D2)
receptor occupancy. The patients receiving haloperidol, a
typical antipsychotic, demonstrated impaired IL, whereas
those receiving olanzapine, an atypical antipsychotic, per-
formed equivalently to controls. Additionally, in the
haloperidol-treated patients significant correlations were
found between IL deficits and striatal D2 receptor occu-
pancy. Similarly, the greater striatal D2 binding of
risperidone relative to other atypical antipsychotics has
been forwarded as the explanation for impaired IL on
risperidone-treated patients in studies also involving
olanzapine (Purdon et al., 2003)a n dc l o z a p i n e( Schérer
et al., 2004). It is unknown if our participants with
schizophrenia had significant striatal D2 blockade or to
what extent this might contribute to the observed relative
decreasedstriatalactivation.Moreover,thepresentinvesti-
gation cannot directly address whether IL is intact in
schizophrenia per se or behaviorally normalized by the
usage of atypical antipsychotic medication.
Inanevokedpotential investigationofcolourpatterns,
Hsieh et al. (2004) recently reported IL deficits in
schizophrenia which were correlated with less gating of
the P50 component. Abnormal P50 evoked potentials
have also been reported in both Parkinson's (Teo et al.,
1997) and Huntington's (Uc et al., 2003) diseases, both
degenerative disorders of striatal pathology. These fin-
dings are consistent with an overall linkage between IL,
striatal function, and schizophrenia as reported in this
study.
The findings of the current study contrast with those
of Kumari et al. (2002), the only other fMRI study of
IL in schizophrenia to our knowledge. However, our
study involved a larger sample and was comprised of
patients taking only atypical antipsychotics, whereas in
the earlier study all patients were on typical anti-
psychotics. Conceivably, the Kumari et al. (2002)
findings may reflect an effect of typical antipsychotics
(as opposed to being an effect of illness) in that the
schizophrenia participants performing a similar implicit
sequence-learning paradigm demonstrated minimal
neural activation. However, an equally plausible ex-
planation would be that their schizophrenia group
showed no behavioural evidence of IL. The authors
acknowledged these points as well making the
recommendation that further fMRI studies be done in
participants receiving atypical antipsychotic drugs,
such as the present one.
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literatureonILinschizophrenia.Most,butnotallstudies
report intact IL in schizophrenia, with sequence learning
studies being the type most likely to yield differential
behavioural performance. The present investigation pro-
duced results that are suggestive of a neural inefficiency
in schizophrenia during implicit sequence learning.
Despite equivalent behavioural performance, the schizo-
phreniagroupdidnotinvokeanasdistributednetworkas
the controls, and in particular failed to equally recruit the
striatum. This proposed neural inefficiency might ac-
count for findings of intact IL in those studies where task
demands are relatively modest (as perhaps in the present
study), but result in impaired IL when the sequencing
task demands exceed the capability of the deficient
neural network.
Another aspect of the discrepancies regarding IL
findings in schizophrenia is the heterogeneity of the
schizophrenia groups between studies and of the illness
itself. It has been adduced that schizophrenia is a hetero-
geneous illness (Clark et al., 1995; Tsuang et al., 1990),
such that only some patients may have IL impairment as
an endophenotype, which could account for the majority
of studies reporting normal IL.
Previous studies have reported associations between
clinicalsymptoms,particularlynegativesymptomsandIL
(Schroderetal.,1996;Schwartzetal.,2003).Wefoundno
correlations between symptoms and behavioural mea-
suresofIL,norwiththeidentifiedneuralactivations.This
may be due to a lack of statistical power, a potential
limitation of our study. However, this would have been
more of a concern if there had been a failure to differen-
tiate the schizophrenia group from the healthy controls
(Type 2 error) in neural responses. Other limitations of
this investigation are the predominance of males, and the
lack of a medication-naïve or -free schizophrenia group.
Future fMRI studies should address the abovemen-
tioned limitations. Ideally, an adequately powered 4-arm
design with a medication-free patient group, two with
patients taking antipsychotic medication (typical and
atypical medication groups), and a healthy control
group, would address the neural mechanisms of IL in
schizophrenia while accounting for (helpful or harmful)
medication effects. Additionally, in order to more fully
explore the neural correlates of IL in schizophrenia,
imaging studies with a broader variety of IL tasks, or
one of incremental difficulty could be utilized. If it is
probable that most patients with schizophrenia are ca-
pable of demonstrating some degree of IL, then by
parametrically adjusting the task a more comprehensive
understanding of the neural processing of IL in schizo-
phrenia could be achieved.
In conclusion, we found a relative lack of striatal
activation in schizophrenia patients on atypical antipsy-
chotic medication during an implicit sequence-learning
task, despite similar behavioral performance to healthy
controls. This result is consistent with convergent evi-
dence of striatal dysfunction in schizophrenia.
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